Malaysia
Search
Sign In
Change Password
Points
Sign Out
Top Medical News
Primary care practitioners will now have access to an expert derived handbook as reference for the treatment of urticaria.
New drug applications approved by US FDA as of 01 - 15 November 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
Cancer cells hijack the cellular programmes that normally get activated during wound repair and keep them activated permanently to drive and sustain malignancy, making cancer akin to a wound that never heals, says an expert at the recent Frontiers in Cancer Science 2018.
A Singapore study has shown that a variety of skin conditions can result from renal transplantation, highlighting the importance of careful dermatological screening and long-term follow-up for patients undergoing such procedure to reduce post-transplant skin complications.
Among psoriasis patients new to systemic medication, adherence to biologics is better than to methotrexate, reports a recent study.
Patients with advanced, unresectable melanoma may derive overall survival (OS) and progression-free survival (PFS) benefits when treated with a nivolumab plus ipilimumab combination or nivolumab alone, according to 4-year results of the phase III CheckMate 067* trial presented at ESMO 2018.
Use of 40% hydrogen peroxide topical solution (HP40), a proprietary, stabilized, high-concentration HP–based topical solution, safely and effectively removes seborrheic keratoses (SKs) of the face, trunk and extremities, with a low risk of inducing pigmentary changes and scarring, a recent study has shown.
Special Reports
The prevalence of allergic diseases in the Asia-Pacific region is expected to rise over the next 20 years, driven by rapid economic development and urbanization. Allergic diseases have high socioeconomic impact by impairing productivity and quality of life, and the impact may be greater in Asia-Pacific than in Europe due to the presence and predominance of perennial allergens.
A wound is a disruption of the normal structure and function of the epidermis. Wounds maybe caused by acute traumatic injury to the skin, or other aetiologies that cause initially intact skin to break down. Recently, Dato’ Dr Ho Teik Kok shared his insights into the importance of micronutrients for wound recovery, stressing on the importance of treating the underlying diseases that may impede wound healing.
DCH Auriga recently held their first Aesthetics and Suturing Workshop under the IMPACT continuing medical education series – a scientific platform that aims to cascade the latest updates on disease management and share best clinical practices among healthcare professionals in Singapore. Two experts on aesthetics and aesthetic surgery shared their insights on suturing techniques and current approaches for scar prevention and management.
Eczema (atopic dermatitis) is a chronic inflammatory skin disease that
can present in many different forms. However, it is principally
characterized by dry skin, intense itching, and the presence of
inflammatory skin lesions. [J Eur Acad Dermatol Venereol
2016;30:604-618; N Engl J Med 2008;358:1483-1494; Lancet
2016;387:1109-1122]
At the 42nd Annual Dermatology Conference 2017 held recently in Kuala Lumpur, Professor Michael J. Cork spoke on the interaction between genetic and environmental factors as a primary event in the development of atopic dermatitis (AD) and highlighted the role of topical calcineurin inhibitors (TCIs) in the management of AD.
The prevalence of atopic dermatitis (AD) in industrialized countries has increased exponentially over the past three decades, currently affecting 15 to 30% of children and up to 10% of adults.1 At the recent official launch event of pimecrolimus (Elidel®, Meda Healthcare Sdn. Bhd.) held at Le Méridien Kuala Lumpur, Professor Thomas Luger provided insights on the pathophysiology of AD and the role of topical calcineurin inhibitors (TCIs) in the management of AD.
CANESTEN HC – Clotrimazole 1% w/w and hydrocortisone 1% w/w cream – Bayer
Conference Reports
An association exists between stress and quality of life (QoL) in patients with psoriasis vulgaris, according to a poster presented at the 23rd Asian-Australasian Regional Conference of Dermatology (RCD 2018) held in Surabaya, Indonesia.
Acidity of the skin appears to be significantly higher in atopic dermatitis (AD) patients than in controls without the condition, indicating that increased skin pH may heighten the risk of developing AD, according to a study.
Most clinical guidelines recommend daily bathing in lukewarm water, followed by the application of moisturizers, in the treatment of atopic dermatitis (AD), according to an expert who presented at the 23rd Asian-Australasian Regional Conference of Dermatology (RCD 2018) held in Surabaya, Indonesia.
Managing paediatric atopic dermatitis remains a huge challenge mainly because of noncompliance to treatment, but this challenge can be addressed by prescribing nonsteroidal, noncalcineurin inhibitor agents providing epidermal repair therapy, according to an expert who spoke at the 23rd Asian Australasian Regional Conference of Dermatology (RCD 2018) held in Surabaya, Indonesia.
Chronic pruritus is a diverse and aetiologically complex skin condition and thus requires a similarly comprehensive treatment approach, according to Dr Siti Aisah who gave a lecture at the recently concluded 23rd Regional Conference of Dermatology (RCD 2018) in Surabaya, Indonesia.
Serum concentration of trace zinc appears to be correlated with premature canities, while trace ferrum and copper are not, according to a poster presented at the recently concluded 23rd Regional Conference of Dermatology (RCD 2018), in Surabaya, Indonesia.
Continued treatment with the anti-interleukin (IL)-23 monoclonal antibody guselkumab generated high efficacy response rates in patients with moderate-to-severe plaque psoriasis, according to findings from the ongoing phase III VOYAGE 2* trial presented at the 2018 American Academy of Dermatology Annual Meeting (AAD 2018) held in San Diego, California, US.
